Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
CJ Rageth, EAM O'Flynn, K Pinker… - Breast cancer research …, 2019 - Springer
Abstract Purpose The second International Consensus Conference on B3 lesions was held
in Zurich, Switzerland, in March 2018, organized by the International Breast Ultrasound …
in Zurich, Switzerland, in March 2018, organized by the International Breast Ultrasound …
Atypical ductal hyperplasia and lobular neoplasia: update and easing of guidelines
AA Lewin, CL Mercado - American Journal of …, 2020 - Am Roentgen Ray Soc
OBJECTIVE. Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and
lobular carcinoma in situ (LCIS) are among high-risk lesions that have been previously …
lobular carcinoma in situ (LCIS) are among high-risk lesions that have been previously …
Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration
Nanoemulsions modified with chitosan (NE-Q) or hyaluronic acid (NE-HA), developed for
intraductal administration of piplartine (piperlongumine) and local breast cancer treatment …
intraductal administration of piplartine (piperlongumine) and local breast cancer treatment …
[HTML][HTML] High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision
A Harbhajanka, HL Gilmore, BC Calhoun - Modern Pathology, 2022 - Elsevier
The vast majority of image-detected breast abnormalities are diagnosed by percutaneous
core needle biopsy (CNB) in contemporary practice. For frankly malignant lesions …
core needle biopsy (CNB) in contemporary practice. For frankly malignant lesions …
Prevalence, impact, and diagnostic challenges of benign breast disease: a narrative review
JL Fraker, CG Clune, SK Sahni, A Yaganti… - … Journal of Women's …, 2023 - Taylor & Francis
Benign breast diseases, which are commonly seen in clinical practice, have various clinical
presentations and implications, as well as management strategies. This article describes …
presentations and implications, as well as management strategies. This article describes …
Lobular neoplasia
L Lunt, A Coogan, CB Perez - Surgical Clinics, 2022 - surgical.theclinics.com
Lobular neoplasia (LN) is a term that describes the continuum of atypical epithelial lesions
originating in the terminal duct-lobular unit (TDLU) of the breast. 1 To predict cancer risk …
originating in the terminal duct-lobular unit (TDLU) of the breast. 1 To predict cancer risk …
The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid …
E Brogi - Virchows Archiv, 2022 - Springer
Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive
epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell …
epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell …
Risk for upgrade to malignancy after breast core needle biopsy diagnosis of lobular neoplasia: a systematic review and meta-analysis
MN Shehata, H Rahbar, MR Flanagan… - Journal of the American …, 2020 - Elsevier
Purpose Lobular neoplasia (LN) detected on breast core needle biopsy is frequently
managed with surgical excision because of concern for undersampled malignancy. The …
managed with surgical excision because of concern for undersampled malignancy. The …
Lobular neoplasia and atypical ductal hyperplasia on core biopsy: current surgical management recommendations
JM Racz, JM Carter, AC Degnim - Annals of surgical oncology, 2017 - Springer
Lobular neoplasia and atypical ductal hyperplasia (ADH) are high-risk breast lesions
associated with an increased risk of breast cancer. Until recently, surgical excision was …
associated with an increased risk of breast cancer. Until recently, surgical excision was …
[HTML][HTML] Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis
MC van Maaren, AO Ávila, JG van Manen… - The Breast, 2021 - Elsevier
Purpose We analysed incidence, treatment, survival, occurrence of ductal carcinoma in situ
(DCIS) and invasive breast cancer (IBC) after lobular carcinoma in situ (LCIS) in the …
(DCIS) and invasive breast cancer (IBC) after lobular carcinoma in situ (LCIS) in the …